Beta adrenergic and muscarinic cholinergic receptors in canine myocardium. Effects of ischemia

J Clin Invest. 1979 Nov;64(5):1423-8. doi: 10.1172/JCI109600.

Abstract

Experimental myocardial ischemia produced in dogs by proximal left anterior descending coronary artery ligation is accompanied by relatively rapid (1 h) increases in the number of (-) [3H]dihydroalprenolol binding sites without changing their dissociation constants in ischemic left ventricular tissue. The changes, persist for at least 8 h and are accompanied by marked decreases in myocardial tissue ischemic region norepinephrine content. In contrast, in the same canine model 1 h of proximal left anterior descending coronary artery ligation did not result in a significant change in the number of [3H]quinuclidynl benzilate binding sites of their dissociation constants. However, the number of [3H]quinuclidynl benzilate binding sites (muscarinic cholinergic receptors) are 50--70% greater than (-) [3H]dihydroalprenolol binding sites (beta adrenergic receptors) in canine left ventricular tissue. Thus, the data suggest that proximal left anterior descending coronary artery occlusion for 1 h significantly increases the number of beta adrenergic receptors in ischemic left ventricular tissue without changing the number of muscarinic cholinergic receptors. Whether the ischemia-produced increase in cardiac beta-receptor content is causally related to increased cyclic AMP levels that develop in ischemic tissue and/or an etiologic factor in arrhythmias originating from ischemic myocardial tissue will have to be determined in additional studies.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Coronary Disease / metabolism*
  • Coronary Vessels / surgery
  • Dihydroalprenolol / metabolism
  • Dogs
  • Female
  • Ligation
  • Male
  • Myocardium / metabolism*
  • Norepinephrine / metabolism
  • Quinuclidinyl Benzilate / metabolism
  • Receptors, Adrenergic / isolation & purification*
  • Receptors, Adrenergic, beta / isolation & purification*
  • Receptors, Adrenergic, beta / metabolism
  • Receptors, Cholinergic / isolation & purification*
  • Receptors, Muscarinic / isolation & purification*
  • Receptors, Muscarinic / metabolism

Substances

  • Receptors, Adrenergic
  • Receptors, Adrenergic, beta
  • Receptors, Cholinergic
  • Receptors, Muscarinic
  • Dihydroalprenolol
  • Quinuclidinyl Benzilate
  • Norepinephrine